Cargando…
Impact of a Targeted Fluoroquinolone Restriction on Antimicrobial Usage at Two Community Hospitals
BACKGROUND: A broad spectrum of activity and excellent oral bioavailability have made the fluoroquinolone (FQ) drug class the first-line option for treating various inpatient and outpatient infections. These advantages have resulted in overuse of FQ, resulting in wide-spread resistance to FQ, increa...
Autores principales: | Borkowski, Jaime, Polisetty, Radhika S, Christensen, Alyssa, Lewis, Steven, Manrique, Luis, Cruz, Jennifer De La |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5632000/ http://dx.doi.org/10.1093/ofid/ofx163.581 |
Ejemplares similares
-
1180. Empiric treatment of uncomplicated intraabdominal infection with cefazolin with or without metronidazole
por: Borkowski, Jaime, et al.
Publicado: (2023) -
1842. Fluoroquinolone Usage Reduction in the Outpatient Setting
por: Mang, Norman, et al.
Publicado: (2018) -
2077. Fluoroquinolone Usage Reduction in the Outpatient Setting
por: Lin, Kevin, et al.
Publicado: (2019) -
2184. Effect of Adjusted CLSI Breakpoints on Center-wide Fluoroquinolone Susceptibilities for Enterobacteriaceae and Pseudomonas aeruginosa: Is It Time to Restrict Empiric Fluoroquinolone Use?
por: Sansom, Sarah, et al.
Publicado: (2019) -
2878. A Regional Antimicrobial Stewardship Collaboration to Address Fluoroquinolones
por: Adenew, Ayne, et al.
Publicado: (2023)